All In Biotech

Drug Trial Radar · NCT02966171

A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies

A Phase I, Open-label, Multi-center, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of HMPL-453 in Patients With Advanced Solid Malignancies

Last checked: Nov 19, 2026Latest source record: Nov 21, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

14

Actual

Start

Jan 2017

Primary completion

Aug 23, 2018

Study completion Aug 23, 2018

Sponsor

Lead sponsor
Hutchison Medipharma LimitedIndustry
Sponsor type
Industry
First posted
Nov 17, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a first-time-in-human, phase I, open-label, dose-escalation study of HMPL-453 in patients with advanced or metastatic solid malignancies who have failed or are intolerable to standard therapies or for whom no standard therapies exist. There are preliminary two stages in this study: a dose-escalation stage (stage 1) and a dose-expansion stage (stage 2). We will decide whether to conduct stage 2 or not one month after the last patient included in stage 1.

Conditions

  • Solid Tumor

Interventions

  • HMPL-453Drug

    oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of DLTs by the NCI CTCAE v4.03Time frame: Cycle 1 (DLT assessment window, 28 days) of multiple dosing peroid

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • St Vincent's Cancer Services

    Sydney, New South Wales, Australia

  • Chris O'Brien Lifehouse

    Sydney, New South Wales, Australia

  • Peninsula and Southeast Oncology

    Frankston, Victoria, Australia

  • Monash Medical Centre

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.